Conmed Corp (CNMD)

Name: Conmed Corp (CNMD) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name CONMED Corp · CIK 0000816956 · NYSE · Electromedical & Electrotherapeutic Apparatus

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, Conmed Corp reported revenue of $1.37B. Revenue grew 5.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.37B.

Key ratios (year ended 2025-12-31)

54.6%

Gross margin

7.5%

Operating margin

3.4%

Net margin

4.6%

Return on year-end equity

5.2%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-10

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$1.37B	$1.37B	$1.31B	$1.24B	$1.05B	$1.01B	$862.46M	$955.10M	$859.63M	$796.39M	$763.52M
Cost of Revenue	$606.35M	$624.25M	$573.98M	$568.50M	$474.23M	$442.60M	$402.16M	$430.38M	$390.52M	$365.35M	$355.19M
Gross Profit	$765.31M	$750.48M	$733.03M	$676.25M	$571.25M	$568.04M	$460.30M	$524.72M	$469.11M	$431.04M	$408.33M
R&D Expense	$60.63M	$55.88M	$54.43M	$52.60M	$47.15M	$43.56M	$40.47M	$45.46M	$42.19M	$32.31M	$32.25M
Operating Income	$110.32M	$102.62M	$200.33M	$120.60M	$70.05M	$109.72M	$46.01M	$79.11M	$71.31M	$46.94M	$37.68M
Net Income	$56.50M	$47.05M	$132.42M	$64.46M	-$80.58M	$62.54M	$9.52M	$28.62M	$40.85M	$55.49M	$14.66M
EPS (Diluted)	n/a	$1.51	$4.25	$2.04	-$2.68	$1.94	$0.32	$0.97	$1.41	$1.97	$0.52
Total Assets	$2.30B	$2.33B	$2.31B	$2.30B	$2.30B	$1.77B	$1.75B	$1.78B	$1.37B	$1.36B	$1.33B
Total Liabilities	$1.26B	$1.29B	$1.34B	$1.47B	$1.55B	$980.58M	$1.04B	$1.06B	$706.87M	$726.53M	$748.41M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$456.90M	$486.44M	$498.49M
Shareholders' Equity	$1.04B	$1.03B	$962.68M	$834.22M	$745.54M	$785.43M	$709.04M	$710.47M	$662.27M	$631.43M	$580.58M
Cash & Equivalents	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$25.86M	$17.51M	$32.62M	$27.43M
Operating Cash Flow	$150.59M	$170.69M	$166.97M	$125.35M	$33.37M	$111.77M	$64.53M	$95.13M	$74.70M	$65.57M	$39.88M
Capital Expenditures	$16.12M	$19.81M	$13.08M	$19.03M	$21.79M	$14.87M	$13.01M	$20.07M	$16.51M	$12.84M	$14.75M
Free Cash Flow	$134.46M	$150.88M	$153.88M	$106.32M	$11.58M	$96.90M	$51.52M	$75.07M	$58.19M	$52.72M	$25.13M
Share Repurchases	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$0
Dividends Paid	$12.38M	$24.75M	$24.65M	$24.50M	$23.96M	$23.26M	$22.82M	$22.60M	$22.44M	$22.31M	$22.21M
Dividends Per Share	n/a	$0.60	$0.80	$0.80	$0.80	$0.80	$0.80	$0.80	$0.80	$0.80	$0.80
Weighted Average Diluted Shares	n/a	31.15M	31.15M	31.55M	30.04M	32.22M	29.46M	29.50M	28.89M	28.17M	27.96M
EPS (Basic)	n/a	$1.52	$4.29	$2.10	-$2.68	$2.14	$0.33	$1.01	$1.45	$1.99	$0.53

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView